Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ELTX
#3621
Elicio Therapeutics, Inc. Common Stock
11.780
0
USD
+0.43%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
+0.43%
Mudança mensal
-4.15%
Mudança em 6 meses
+17.80%
Mudança anual
+17.80%
Fechamento anterior
11.730
0
Abrir
11.780
0
Bid
Ask
Mínimo
11.780
0
High
11.780
0
Volume
15
Mercados
Ações
Cuidados de saúde
ELTX
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
15.95 M
16 M
16.34 M
17.49 M
18.4 M
—
Valuation ratios
Enterprise value
83.78 M
80.19 M
113.38 M
180.44 M
137.28 M
511.29 M
Price to earnings ratio
-1.2
-1.55
-1.93
-3.42
-3.09
-9.99
Price to sales ratio
404.13
-28.57 K
13.27 K
16.69 K
—
—
Price to cash flow ratio
-1.68
-2.18
-2.98
-4.02
-3.3
-12.48
Price to book ratio
-5.5
-3.45
-5.07
105.85
74.5
171.83
Enterprise value to EBITDA ratio
-2.02
-1.91
-2.69
-4.44
-3.85
-12.88
Profitability ratios
Return on assets %
-0.5
-0.4
-0.36
-0.36
-0.3
-1.41
Return on equity %
1.24
-1.26
-5.76
-2.64
-4.72
-14.38
Return on invested capital %
-554.41
-466.76
-481.73
-410.38
-460.79
-1 819.66
Gross margin %
100
—
—
—
—
—
Operating margin %
-168.46 K
—
—
—
—
—
EBITDA margin %
-166.01 K
—
—
—
—
—
Net margin %
-175.05 K
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
1.8
1.83
2.28
3.29
2.38
9.79
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0
0
0
Solvency ratios
Debt to assets ratio
0.71
0
0.32
0.34
0.36
1.02
Debt to equity ratio
-1.77
0
5.09
2.55
5.75
13.39
Long term debt to total assets ratio
0.71
0
0.32
0.34
0.36
1.02
Long term debt to total equity ratio
-1.77
0
5.09
2.55
5.75
13.39
Per share metrics
Operating cash flow per share
-0.72
-0.78
-0.56
-0.66
-0.44
-2.45
EBIT per share
-1.1
-0.83
-0.63
-0.48
-0.58
-2.52
EBITDA per share
-1.09
-0.82
-0.62
-0.48
-0.57
-2.49
Total debt per share
1.64
0
0.58
0.58
0.61
1.78
Cash per share
1.44
1.42
1.38
1.23
1.21
5.24
Net current asset value per share
1.7
1.62
1.41
1.29
1.26
5.57
Tangible book value per share
-0.93
0.69
0.11
0.23
0.11
1.14
Working capital per share
0.75
0.74
0.79
0.9
0.73
3.15
Book value per share
-0.93
0.69
0.11
0.23
0.11
1.14
Notícias
Is Aura Biosciences (AURA) Outperforming Other Medical Stocks This Year?
Elicio Therapeutics lança nova oferta de ações de até US$ 100 milhões
H.C. Wainwright eleva preço-alvo da Elicio Therapeutics para US$ 17
H.C. Wainwright raises Elicio Therapeutics price target to $17
Rodman & Renshaw inicia cobertura da Elicio Therapeutics com recomendação de compra
Rodman & Renshaw initiates Elicio Therapeutics stock with buy rating
Is Quest Diagnostics (DGX) Stock Outpacing Its Medical Peers This Year?
Elicio Therapeutics (ELTX) Upgraded to Buy: Here's Why
Elicio reports antigen spreading in 87% of evaluated cancer patients
Elicio Therapeutics appoints Marc Wolfgang as chief technology officer
Elicio reports strong immune responses in phase 2 KRAS cancer vaccine trial
Elicio’s cancer therapy shows immune response across diverse HLA types